Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shandong Quanxi Biotech is a Chinese biotechnology company specializing in in vitro diagnostics (IVD) and molecular testing. Based in Jinan, the company develops and manufactures nucleic acid extraction systems, PCR detection kits, and automated laboratory instruments for clinical and research use. In addition to its commercial diagnostic portfolio, Shandong Quanxi Biotech is active in early-stage biopharmaceutical research, focusing on mesenchymal stem cell therapies and microRNA-based treatments for digestive system disorders. The company's R&D efforts include the development of novel candidates targeting specific microRNA markers to address unmet needs in gastroenterology. Shandong Quanxi Biotech aims to integrate advanced diagnostic tools with innovative therapeutic approaches to improve patient care across infectious diseases and oncology.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shandong Quanxi Biotech.